Journal of Pharmacology and Experimental Therapeutics Publication

This important article is being published in Journal of Pharmacology and Experimental Therapeutics (abstract) and describes the promising pharmaceutical properties of the lead compound, ABC294640.

Dr. Charles D. Smith, President and CEO of Apogee, stated the company is pleased to publish this important information in such a respected and high impact journal.¬† He believes it further validates the science and the importance of Apogee’s novel sphingosine kinase inhibitor program.

Powered by THE BRAVO GROUP & ARCHODA: CREATE SOMETHING UNIQUE